Delivery Order SPE2DB22D6029-SPE2DB25FLVVT
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $47,320.66 to AmerisourceBergen Drug Corp for the supply of Dasatinib 100 mg tablets (30-count units). This competitive award, issued on September 9, 2025, with an ultimate completion date of September 10, 2025, represents a firm fixed-price delivery order with no set-aside designation. The pharmaceutical product will be delivered to AmerisourceBergen's corporate headquarters location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 24, 2025, for the supply of Dasatinib 100 mg tablets in a 30-count package, with a contract ceiling value of $4,816.96. This non-set-aside, competitively awarded delivery order employs firm fixed pricing and is scheduled for completion by April 25, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Dasatinib 100 mg tablets in quantities of 30. This contract, valued at $6,240.24, represents a firm fixed price delivery order with no set-aside designation, indicating it was awarded through open competition. The order is scheduled for completion by August 29, 2025, with performance taking place at AmerisourceBergen's corporate office in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Dasatinib 80 mg tablets (30-count packaging) under a firm fixed-price contract valued at $82,393.53. The order is set to be completed by July 29, 2025, with fulfillment occurring at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract issued against AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $23,157.77 to AmerisourceBergen Drug Corp for the supply of Dasatinib 80 mg tablets (30-count units) under a firm fixed-price contract type. The order was competitively awarded without set-aside designation and carries an ultimate completion date of September 10, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Dasatinib 100 mg tablets in quantities of 30 units. This is a firm fixed-price delivery order with a ceiling value of $37,364.76, with an ultimate completion date of August 15, 2025. The contract is not set-aside and was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,448.37 to AmerisourceBergen Drug Corp for the supply of Dasatinib 80 mg tablets (30-count units) with an ultimate completion date of August 5, 2025. The contract was competitively awarded with no set-aside designation and utilizes firm fixed pricing. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $9,193.03 to AmerisourceBergen Drug Corp for Dasatinib 50 mg tablets (60-count supply) on August 11, 2025, with a completion date of August 12, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's existing...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 60 tablets of Dasatinib 50 mg, with a contract value of $12,233.56. This is a firm fixed price delivery order awarded on July 22, 2025, with an ultimate completion date of July 23, 2025. The contract does not utilize a set-aside designation, indicating it was competitively awarded. Performance will be executed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Dasatinib 100 mg tablets in quantities of 30 units. This is a firm fixed price delivery order with a ceiling value of $39,326.10 and an ultimate completion date of September 9, 2025. The contract carries no set-aside designation and was competitively awarded. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order...
- SPE2DB22D6029Indefinite Delivery Contract
- SPE2DB22D6029-SPE2DB25FLVVTDelivery Order
The Defense Logistics Agency awarded a $24,781.68 delivery order to AmerisourceBergen Drug Corp for the supply of Dasatinib 100 mg tablets in quantities of 30, with an ultimate completion date of September 5, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and represents a child order under AmerisourceBergen's larger contract vehicle with the agency. The pharmaceutical product will be delivered to the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime vendor contract serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard. The current Dasatinib order supports federal medical procurement needs as part of the company's established role as a critical pharmaceutical distributor for military and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $24.8k | 9/4/25 |